Abacus Global Management, Inc. (ABX) Q2 2024 Earnings Report, Transcript and Summary

Greetings and welcome to Abacus Life Second Quarter '24 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I would now like to turn the conference over to Garrett Edson of ICR. Thank you. You may begin.

Good day, ladies and gentlemen. Thank you for standing by. Abacus Life, our first participants on this call to the Investor webpage www.abacuslife.com/investors for the press release, the investor information and filings with the SEC for a discussion of the risks that can affect the business. Abacus Life specifically refers participants to the presentation furnished today on Form 8-K with Securities Exchange Commission, and to remind listeners that some of the comments today may contain forward-looking statements, and as such will be subject to risks and uncertainties, which if they materialize can materially affect results. Reference is made to the section titled forward-looking statements in the company's earnings press release for the first quarter of 2024 which is incorporated herein by reference. We note, forward-looking statements, whether written or oral include, but are not limited to Abacus Life's expectation or prediction of financial and business performance and conditions as well as its competitive and industry outlook. Forward-looking statements are subject to risks, uncertainties and assumptions, including the risk factors set forth in item 1A of our most recent 10-K, which if they materialize could materially affect results and such forward-looking statements do not guarantee performance and Abacus Life gives no such assurances. Abacus Life is under no obligation and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, historical data pertaining to the operating results and other performance indicators applicable to Abacus Life are not necessarily indicative of results to be achieved in succeeding periods. I will now turn the call over to Jay Jackson, Chief Executive Officer of Abacus Life.

Thank you to everyone listening today for your interest in Abacus, and welcome to our 2024 second quarter earnings call. With me today is our Chief Financial Officer, Bill McCauley, and after our remarks, we'll open it up to your questions. It was another quarter of excellent performance for Abacus Life, as we continue to successfully execute on our key strategic initiatives and further solidifying our position as a leading market maker and global alternative asset manager, which will have nearly $3 billion in assets under management post acquisitions. For the second quarter of 2024, we more than doubled total revenue year-over-year to $29.1 million and recorded strong earnings, growing adjusted EBITDA by 83% year-over-year to $16.7 million and generating a 75% year-over-year increase in adjusted net income to $11.8 million or $0.18 per diluted share. Our second quarter performance underscores our thoughtful investments in marketing, which continue to yield excellent results by driving significant year-over-year increases in our direct-to-consumer originations. Meanwhile, the strength of our partnerships with carriers and reinsurers remains a key contributor to our strong performance in both revenue and adjusted EBITDA. Bill will be along shortly to discuss our second quarter financial performance in further detail. In addition to our exceptional quarterly financial results, we also made substantial progress with respect to our long-term strategy as we outlined during our Investor Day in June, along with our core business of acquiring life insurance policies, we are focused on expanding our complementary lifespan based financial products. Since our last earnings call, we achieved several key strategic milestones. In a pivotal moment for our ABL Wealth division, subsequent to the quarter end, we announced a definitive agreement to acquire Carlisle Management Company, a premier Luxembourg based investment manager in the life settlement space for approximately $200 million. This acquisition will add approximately $2 billion in assets under management and is fully aligned with our strategy to become a global alternative asset manager. In addition to being a great culture fit, Carlisle further enhances Abacus's offering to institutional investors seeking attractive risk adjusted returns with low correlation to other asset classes. Carlisle has a most impressive and longstanding track record as a fund manager in the life settlement industry and is geographically diverse client base stands to significantly complement our efforts to become a global financial leader by incorporating Carlisle's expertise and robust portfolio into our offerings we are strategically positioning ABL Wealth at the heart of our mission to deliver sophisticated investment solutions for the life settlement market. This acquisition highlights our dedication to providing exceptional value and expanding our capabilities to serve a wider range of investor. Along with Carlisle, last week we entered into an agreement to acquire FCF Advisors, a New York based asset manager and index provider specializing in free cash flow focused investment strategies. FCF Advisors has a suite of core thematic free cash flow equity strategies and offers over 50 customizable free cash flow index strategies, covering eight global equities allocations. The deal will add approximately $600 million in assets under management and further accelerates the expansion of ABL Wealth with a diverse lifespan based suite of products. In late June, we successfully closed an oversubscribed public offering of 11.5 million shares of common stock, including full exercise of the underwriter’s option, which further broadened our investor base and enhanced our liquidity position. Through this offering, we raised over $90 million in proceeds, which we have rapidly deployed into additional life settlement policies as well as advancing our overall business strategy. Finally, during the quarter, we established a national distribution relationship with Amcor, one of the largest national insurance marketing organizations in the United States. This partnership will leverage Amcor's extension network of over 40 broker general agencies to offer protection and retirement solutions to thousands of financial professionals, institutional clients and other distribution partners nationwide. As a preferred partner for life settlement solutions, Abacus will provide its expertise to Amcor's affiliated member firms. This collaboration highlights our commitments to client-centric solutions and enhancing our ability to educate policy holders about the value of their policies and empowering them to make informed financial decisions. All of our achievements over the past few months clearly underscore our relentless commitment to constant innovation through our wealth of longevity data and actuarial data and actuarial technology, offering an incredible value proposition for our clients in firmly solidifying Abacus as a pioneering global alternative asset manager and market maker. Looking ahead, we're incredibly excited to build upon our success and capitalize on the vast growth opportunities before us. By continuing to leverage our successful business model, exceptional team of experts and extensive proprietary data and technology, we are strategically positioned for sustainable and profitable growth, ensuring long-term value creation for our shareholders. With that, I'll now hand it over to our CFO, Bill McCauley to discuss the specifics of our second quarter results in financials.

Thanks, Jay. And hello everyone. As Jay mentioned, we delivered another strong quarter of top line growth and profitability at Abacus. The key driver of our business performance continues to be our highly efficient origination platform, while we continue to build our other verticals that will contribute to our future earnings. In the second quarter of 2024, origination capital deployed was $104.7 million compared to $59.8 million in the prior year period. While we grew policies purchased 95% to 275% compared to 141% in the prior year period. Total revenue in the second quarter 2024 more than doubled to $29.1 million compared to $11.4 million in the prior year period. The increase was primarily due to higher active management revenue. As of June 30, 2024, Abacus held 458 policies of which 452 are accounted for under the fair value method and six are accounted for using the investment method, which is cost plus premiums paid. As a reminder for all policies purchased after June 30, 2023, the company has elected to account for these under the fair value method going forward. For policies purchased before June 30, 2023, the company elected to use the fair value method or the investment method. Turning to expenses, total operating expenses excluding unrealized and realized gains and losses in the change in fair value of debt for the second quarter 2024 were approximately $18.9 million compared to $1.3 million in the prior year period. We would note that second quarter 2024 total operating expenses included $6.2 million of non-cash stock compensation expense, and $0.8 million of public company related expenses, both of which did not occur in the prior year period. Beginning in the third quarter, we will anniversary these non-cash equity compensation and public company expenses. We also increased sales and marketing expenses by approximately $1.9 million compared to the prior year period, which assisted in accelerating our growth profile. The company typically realizes the benefit of marketing spend within 90 to 120 days. Adjusted EBITDA for the quarter grew 83% to $16.7 million compared to $9.1 million in the prior year period. Adjusted EBITDA margin was 57.5% for the quarter compared to 80.4% in the prior year period. GAAP net income attributable to stockholders for the quarter was $0.8 million compared to $6.8 million in the prior year period. On an adjusted basis, excluding non-cash stock compensation, business acquisition costs, amortization and change in fair value of warrant liability, net income for the second quarter of 2024 grew 75% to $11.8 million compared to $6.8 million in the prior year period. Now turning to our balance sheet metrics. On an annualized basis, adjusted return on equity and adjusted return on invested capital for the three month period ended June 30, 2024 were both 18%, reflecting our highly-profitable business model. As of June 30, 2024, the company had cash and cash equivalents of $91.3 million, balance sheet policy assets of $208.7 million and outstanding long-term debt of $151.3 million. In summary, we are pleased with our strong results delivering triple-digit growth on our top-line as well as solid profitability on an adjusted basis. We remain very excited about the growth opportunities ahead and are well-positioned to execute on our long-term plans. I will now turn it back to our CEO, Jay Jackson, for our closing comments.

Thanks, Bill. To sum up, we remain well-positioned to continue utilizing our deep expertise within the life planning space to further capitalize on a massive market opportunity. We are making steady progress on the path to becoming a global alternative asset manager, while our incredible wealth of longevity data is opening up many new doors into several new verticals, which should further charge our growth capabilities. And we will continue to do this, while ensuring that we sustain and grow our profitability just as we've done over the last 20 years. I'd like to thank you all for joining us today, and we appreciate your interest in Abacus Life. We will now field any questions.

[Operator Instructions] Our first question is from Crispin Love with Piper Sandler.

First, can you just talk a little bit about deployment and capacity? You've raised $90 million plus in June, clearly put some of that to work pretty quickly based on the results. So can you just discuss, when you expect to deploy that full amount and then capacity for deployment and opportunities going forward, as you look to the back half of the year and into 2025?

When we thought about this, when we were even managing the follow-on investment when we talked about the deployment of that capital was to make things both sustainable and profitable over time. And we're in a very, I think exciting period for our industry in a sense that the broadening of the message has really certainly increased policy flow for us and thus, the deployment of capital we absolutely were able to -- we had some pent-up inventory and we're able to put some of that capital to work right away even before Q2 even though we closed on the follow-on, June 20. So even in that short amount of time, we were able to get that capital deployed. I think, we had spoken prior [Technical Difficulty] specifically, we expect to have a majority of that capital deployed before year end, probably sooner than that. It could be as early as Q3, which is exciting, right? That's what we wanted to do, get that capital deployed, get that ROE to work for all of our shareholders and investors. And the opportunity only continues to grow through this year and really through next year as well. We think it's also, even when you think about rates and you think about the markets themselves, this is really a market that's designed for us, whether that's volatile or different types of volatility or whether it's different types of interest rates. We think that this is a great market for us.

And then just another one on adjusted EBITDA. You've generated about $28 million in the first half of the year. Can you just talk a little bit about expectations for the full year? As I kind of look at my model, just simplistically doubling that gets you to $56 million, but you did add the capital also took advantage of some opportunities late in the second quarter, which might not recur. So just I'm curious on how we should look at the cadence of EBITDA for the second half of the year.

Yes, I think the cadence of the EBITDA additional capital, so when we look at Q3, Q4, the way that we're looking at this is, is that yes, we had a phenomenal Q2, we want to manage expectations in Q3, Q4, I think, the numbers that you have put forth and other analysts, we think that we're tying out to those and everything looks very positive. Obviously, you can't predict everything that's going to happen in the future but based upon the capital raise and based upon, like I said, the sustainability and profitability of the current business we feel very good about the numbers throughout the end of the year.

And then just one very quick one for housekeeping model, can you share what originated face value was in the quarter?

Yes, total originated face value in the quarter. I know Bill has that number that exact number, which will get to you. One of the things that we did do Crispin that I just want to highlight is that when we think about origination, it can come in one of two areas. It can come direct from the policy holder but there can also be opportunities where we see other asset managers that are winding down their funds and they want to potentially, opportunistically sell the remaining other assets so that they can return their capital back to their shareholders. And so, we have been able to take advantage of that as well. And so, when we look at discount rates on a go forward [Technical Difficulty].

Excuse me, Mr. Jackson, we are having a little trouble with your line. It keeps cutting out a little bit.

I don't know, if that. Bill if you wouldn't mind jumping on and just giving him the actual number and then we can kind of tie out the rest of that.

Yes, sure. So, total originated face value for the quarter was $447 million. And what Jay, which was mentioning is that before he cut out, is that we had opportunities to buy policies outside of just our origination platform. And that's what also contributed to the high volume in the quarter.

Our next question is from Andrew Kligerman with TD Securities.

My first question is around active management and the revenue that came in. I mean more than doubled. It's a big number at $27 million, a little more than we had anticipated. Could you help frame just sort of -- is this sort of a base number now, how do you see that trending over the next year or two?

Yes. I don't know if my sound was repaired or not. Is that any better?

That's sound good Jay.

I think that when we look at Q2, this is about being able to put some of the capital to work that we were able to expand from our follow on investments. The way that I look at this is that you this is sustainable and profitable and we are in one key indicator there is, when you look at the return on equity, we didn't see a fall off on ROE. However, we also still have a significant higher cash balance sheet that we're putting money to work here in Q3 as well. So this is the type of business that when we look at discount rates and the opportunities that we have to buy, let's say policies it's incredibly accretive for us right now. And so without pull -- trying to pull out the crystal ball and go too far out in advance, I think the way that I would look at it is that from a modeling perspective and the way that we see this through the end of the year, I would expect us to maintain a lot of the things that -- a lot of the modeling numbers that you had laid out.

And then with respect to M&A, two really nice acquisitions in Carlisle is being more of a pure play life settlements and then FCF, which is a little more diverse. So, as we kind of look forward Jay, what are you thinking about M&As and will they be more along the lines of FCF or are there more Carlisle type deals out there?

I think that Carlisle was a special opportunity for us. We had known them for so long, 15-plus year track record. I don't think there's a lot of companies like Carlisle out there. I think from our focus is let's look at that business that has 2 billion in assets under management, primarily from offshore investors, and continue to grow and expand that brand. And FCF is the same in the sense that FCF has got a great track record. We want to expand the idea of providing ETF models specifically related to someone's lifespan. So from our perspective, the way that we look at M&A is let's make sure that we're integrating successfully the companies that we've been able to acquire and drive profitability there. Because I think that we've got best in class in both of those businesses right now. And if we're [Technical Difficulty].

Jay, you have cut out again. Bill, could you maybe take up while I fix Jay’s line?

Absolutely. Andrew, we will continue to be opportunistic with regards to M&A. as Jay mentioned, Carlisle was a pure life settlement play in our industry, made sense from an asset management side. FCF is a great fit for ABL Wealth model. And as we look to build out ABL Wealth providing financial advice based on longevity, we think that's a great fit and we'll continue to be strategic on the M&A side going forward.

And one last one on the Abacus Tech front, I know you've outlined in the past that potential clients would be governments, insurance companies, pensions. It seems like pensions would be the big area and maybe you could touch on progress to date if you've had any wins and kind of where you see that going.

We are still having trouble with Jay's line. I'm trying to get connected in.

I can take that one. So ABL Tech continues to grow. I mean, we're adding on new clients here now that we've deployed the service. And so, we continue to see that as a growth opportunity for fee recurring earnings. So that is going as planned to date.

And we will move on to the next question, which is Matthew Howlett with B. Riley Securities.

Terrific results. I mean, I want to talk about the margins here. It just beat us and impressed again. What are you seeing out there on the acquisition front? And was there anything particular this quarter? Did you buy bigger policies? Was there a certain channel that was better than the others? Just give me, what you're seeing out there in terms of margins and pricing?

Hopefully, you all can hear me better now. The EBITDA margin went up and we are seeing really interesting opportunities and I kind of highlighted the two areas, where we're being able to acquire directly from policyholders as well as institutionally. And I think on an institutional basis, where we're able to acquire some very strategic opportunities related to other portfolios, we definitely saw some of that in Q2. Historically, we haven't seen as much opportunity there as we're seeing today as some funds are starting to wind down some of their strategies and they can't sell into the next one. On a go forward basis, we think that, that's going to continue to be a strategy that we want to expand in addition to our regular origination, which is directly to the policyholder. And I would also just add too, when you add more origination, which is what we've done, we have focused specifically on educating consumers, educating financial advisors, broadening our origination from large financial firms. When you do that, you're able to get a broader set of policies to purchase at much better rates.

And in terms of just the general market, I mean would that with your direct program? I realize you can go to these institutions and get low hanging fruit when it's available, but the market size, the share size you have obviously, is it still as big as, as you thought it was going to be?

It is. And I would argue, it's even bigger, right? Like, we have pent up demand and there's specific segments of the market that we are absolutely thrilled about opportunistically, where I think as more and more people are starting to really utilize this asset, as something for their estate plan, I think that, that's creating a significant amount of opportunity. So for us, Matt, we see this continuing. I mean, this is the type of opportunity that from a profit margin and a discount rate perspective, we haven't seen in years. And we should be putting more and more capital to work where the opportunities lie.

It's incredible. And you're putting us in more marketing dollars to work and we'll see the impact of that. Like you said, it's a sort of some lead time before you see more of that coming through that channel. That look, that's perfect. I mean, it's amazing how quickly you put that capital to work from the raise. On the buyback -- insurance buyback, did it seem if there's any contribution this quarter, did I see it right or is that just 1B every quarter-to-quarter?

Yes. When you look at the buyback perspective sometimes it's lumpy in a sense that it just depends on when transactions close, like they're not as -- they're not always at the last few days of the month or the week. Sometimes you're building up inventory to better structure those. And I like to point out is that even with or without that buyback in place, we still had just a really strong quarter. And I think that's the consistency that you're looking for is that yes, absolutely. Working with the life insurance companies and potentially reinsurers is a great opportunity, but we still have a phenomenal underlying business that generates great returns. And as that business continues to grow that will just grow on top of this.

Yes. That's where I was going. The margin would have been stronger if that was involved this quarter. And then the last thing is you've raised the equity, you did the Carlisle deal, which -- what was more equity than debt? I mean, when you look at you've delevered a bit and you've got your 28 no trading above par and you've got possibly interest rates coming down. Jay, what's the capacity to add more debt capital when it's available? Are you looking at things like structured finance? I mean, just walk me through the balance sheet here. It just seems like it's really improved since the deal.

It has and the balance sheet is really strong and we're taking advantage, I think of every opportunity that would present itself specifically around capital. Assuming that here we've got this great inventory of contracts with this level of ROE that we should be purchasing and even if you apply this to the M&A, the M&A deals didn't really require much capital. A lot of almost all of that was either through bond or through equity rollover. We're deploying this capital into those assets, which now how do we best utilize that? Is it through potential adding some more debt to the balance sheet? Certainly, taking a close look at that, particularly, as we're watching closely what rates do, and if rates come down substantially, that'll be at the forefront of our mind. And what does equity look like going forward too. Although, we had a very successful follow-on equity raise in June, what we're hearing from shareholders and investors is that there's significantly more appetite for additional equity to purchase. And so, we're also taking that into consideration as well.

Now, listen with the acquisitions you did, I mean, just I mean, you guys, I mean, it seems like markets willing to give you capital just given how the growth in the business really congratulations and look forward to the next quarter.

We have reached the end of our question-and-answer session. I would like to turn the call back over to Jay for closing remarks.

Great. Thank you again, everyone. And we are absolutely thrilled to highlight another strong and consistent and profitable quarter for Abacus. We are just as excited about our future and the opportunities that we have as our business and our company, and we look forward to continuing that journey with each and every one of you. I hope everyone has a great day today. If you have any follow-up or further questions that you would like have answered, please feel free to reach out to Bill and myself and we're happy to schedule some additional time with you. Have a great day, everybody.

Thank you. This will conclude today's conference. You may disconnect your lines at this time and thank you for your participation.